Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use

• Status: Active, not recruiting
• Trial end date: 2021-09-09
• Target enrollment: 0
• Participant gender: Female

Summary

This study is designed to assess whether consumers select and use norgestrel 0.075 mg, a progestin only pill for contraception, in a manner consistent with the OTC package directions in an Over-the-Counter (OTC)-like setting.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: HRA Pharma
• Treatments: Contraceptive Agents; Contraceptives, Oral; Norgestrel

Criteria

Inclusion Criteria:

• Women who are willing to purchase (in the pharmacies) or be provided (in the clinics, for women younger than 18 years old) oral contraception for their own use for the purposes of the study

Exclusion Criteria:

• Cannot read, speak and understand English

• Cannot see well enough to read information on the label